BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Salpietro V, Zollo M, Vandrovcova J, Ryten M, Botia JA, Ferrucci V, Manole A, Efthymiou S, Al Mutairi F, Bertini E, Tartaglia M, Houlden H; SYNAPS Study Group. The phenotypic and molecular spectrum of PEHO syndrome and PEHO-like disorders. Brain 2017;140:e49. [PMID: 28899015 DOI: 10.1093/brain/awx155] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Naim A, Accogli A, Amadori E, D'Onofrio G, Madia F, Tortora D, Zara F, Striano P, Salpietro V, Severino M. Abnormal course of the corticospinal tracts in KIF5C-related encephalopathy. Eur J Med Genet 2022;:104622. [PMID: 36122673 DOI: 10.1016/j.ejmg.2022.104622] [Reference Citation Analysis]
2 Casto C, Dipasquale V, Ceravolo I, Gambadauro A, Aliberto E, Galletta K, Granata F, Ceravolo G, Falzia E, Riva A, Piccolo G, Cutrupi MC, Striano P, Accogli A, Zara F, Di Rosa G, Gitto E, Calì E, Efthymiou S, Salpietro V, Houlden H, Chimenz R. Prominent and Regressive Brain Developmental Disorders Associated with Nance-Horan Syndrome. Brain Sci 2021;11:1150. [PMID: 34573171 DOI: 10.3390/brainsci11091150] [Reference Citation Analysis]
3 Riva A, Gambadauro A, Dipasquale V, Casto C, Ceravolo MD, Accogli A, Scala M, Ceravolo G, Iacomino M, Zara F, Striano P, Cuppari C, Di Rosa G, Cutrupi MC, Salpietro V, Chimenz R. Biallelic Variants in KIF17 Associated with Microphthalmia and Coloboma Spectrum. Int J Mol Sci 2021;22:4471. [PMID: 33922911 DOI: 10.3390/ijms22094471] [Reference Citation Analysis]
4 García-Ruiz S, Gil-Martínez AL, Cisterna A, Jurado-Ruiz F, Reynolds RH, Cookson MR, Hardy J, Ryten M, Botía JA; NABEC (North America Brain Expression Consortium). CoExp: A Web Tool for the Exploitation of Co-expression Networks. Front Genet 2021;12:630187. [PMID: 33719340 DOI: 10.3389/fgene.2021.630187] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Sabaie H, Ahangar NK, Ghafouri-Fard S, Taheri M, Rezazadeh M. Clinical and genetic features of PEHO and PEHO-Like syndromes: A scoping review. Biomed Pharmacother 2020;131:110793. [PMID: 33152950 DOI: 10.1016/j.biopha.2020.110793] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Nicita F, Ginevrino M, Travaglini L, D'Arrigo S, Zorzi G, Borgatti R, Terrone G, Catteruccia M, Vasco G, Brankovic V, Siliquini S, Romano S, Veredice C, Pedemonte M, Armando M, Lettori D, Stregapede F, Bosco L, Sferra A, Tessarollo V, Romaniello R, Ristori G, Bertini E, Valente EM, Zanni G. Heterozygous KIF1A variants underlie a wide spectrum of neurodevelopmental and neurodegenerative disorders. J Med Genet 2021;58:475-83. [PMID: 32737135 DOI: 10.1136/jmedgenet-2020-107007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
7 Ekici A, Yılmaz İ, Görükmez O, Orcan CG, Dorum S. May PEHO Syndrome be a Clinical Entity Associated with Early Onset Encephalopathies? Ann Indian Acad Neurol 2020;23:401-3. [PMID: 32606555 DOI: 10.4103/aian.AIAN_331_19] [Reference Citation Analysis]
8 Õunap K, Muru K, Õiglane-Shlik E, Ilves P, Pajusalu S, Kuus I, Wojcik MH, Reimand T. PEHO syndrome caused by compound heterozygote variants in ZNHIT3 gene. Eur J Med Genet 2020;63:103660. [PMID: 31048081 DOI: 10.1016/j.ejmg.2019.04.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Samanta D, Gokden M. PEHO syndrome: KIF1A mutation and decreased activity of mitochondrial respiratory chain complex. J Clin Neurosci 2019;61:298-301. [PMID: 30385166 DOI: 10.1016/j.jocn.2018.10.091] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
10 Chitre M, Nahorski MS, Stouffer K, Dunning-davies B, Houston H, Wakeling EL, Brady AF, Zuberi SM, Suri M, Parker APJ, Woods CG. PEHO syndrome: the endpoint of different genetic epilepsies. J Med Genet 2018;55:803-13. [DOI: 10.1136/jmedgenet-2018-105288] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
11 Hady-Cohen R, Ben-Pazi H, Adir V, Yosovich K, Blumkin L, Lerman-Sagie T, Lev D. Progressive cerebello-cerebral atrophy and progressive encephalopathy with edema, hypsarrhythmia and optic atrophy may be allelic syndromes. Eur J Paediatr Neurol 2018;22:1133-8. [PMID: 30100179 DOI: 10.1016/j.ejpn.2018.07.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
12 Imagawa E, Yamamoto Y, Mitsuhashi S, Isidor B, Fukuyama T, Kato M, Sasaki M, Tanabe S, Miyatake S, Mizuguchi T, Takata A, Miyake N, Matsumoto N. PRUNE1 ‐related disorder: Expanding the clinical spectrum. Clin Genet 2018;94:362-7. [DOI: 10.1111/cge.13385] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ferrucci V, Pennino FP, Siciliano R, Asadzadeh F, Zollo M. A competitive cell-permeable peptide impairs Nme-1 (NDPK-A) and Prune-1 interaction: therapeutic applications in cancer. Lab Invest 2018;98:571-81. [DOI: 10.1038/s41374-017-0011-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]